Clinical Research Directory
Browse clinical research sites, groups, and studies.
Artificial Intelligence for the Intra-procedural Assessment of Uterine Artery Embolization
Sponsor: Emanuele Barabino
Summary
Uterine artery embolization is a minimally invasive treatment for symptomatic uterine fibroids, but intra-procedural assessment of embolization adequacy currently relies on subjective angiographic criteria. This study evaluates a proprietary angiographic analysis software (AQ-VERO) that extracts quantitative time-to-density perfusion metrics in real time. The study aims to (1) validate the accuracy and reproducibility of AQ-VERO during uterine artery mebolization, and (2) develop an AI-based decision support system using AQ-VERO-derived metrics to improve objective intra-procedural assessment of treatment endpoints.
Official title: Validation and Implementation With Artificial Intelligence of Software for the Intra-procedural Assessment of Uterine Artery EMBOlization
Key Details
Gender
FEMALE
Age Range
18 Years - 55 Years
Study Type
OBSERVATIONAL
Enrollment
250
Start Date
2025-12-01
Completion Date
2027-05-31
Last Updated
2025-11-19
Healthy Volunteers
No
Conditions
Locations (1)
IRCCS OSpedale Policlinico San Martino
Genova, Genova, Italy